{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:55:55Z","timestamp":1762660555899,"version":"3.32.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.7759\/cureus.76705","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T06:42:21Z","timestamp":1735713741000},"source":"Crossref","is-referenced-by-count":1,"title":["Statistical Analysis of Multiple Vaccine Effectiveness Against COVID-19 Variants: Integrating Immune Response Dynamics"],"prefix":"10.7759","author":[{"given":"Jiwoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyosoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen KG","year":"2020","unstructured":"Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020, 26:450-2. 10.1038\/s41591-020-0820-9","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jairtraman.2021.102062","article-title":"COVID-19 pandemic and air transportation: successfully navigating the paper hurricane","volume":"94","author":"Sun X","year":"2021","unstructured":"Sun X, Wandelt S, Zheng C, Zhang A. COVID-19 pandemic and air transportation: successfully navigating the paper hurricane. J Air Transp Manag. 2021, 94:102062. 10.1016\/j.jairtraman.2021.102062","journal-title":"J Air Transp Manag"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.07.003","article-title":"COVID-19 vaccines","volume":"71","author":"Ndwandwe D","year":"2021","unstructured":"Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Curr Opin Immunol. 2021, 71:111-16. 10.1016\/j.coi.2021.07.003","journal-title":"Curr Opin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/bbrj.bbrj_280_21","article-title":"A review on COVID\u201119 vaccinations","volume":"6","author":"Garg K","year":"2022","unstructured":"Garg K, Talwar D, Mahajan SN, et al.. A review on COVID\u201119 vaccinations. Biomed Biotechnol Res J. 2022, 6:50-3. 10.4103\/bbrj.bbrj_280_21","journal-title":"Biomed Biotechnol Res J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2027160","article-title":"The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review","volume":"18","author":"Mohammed I","year":"2022","unstructured":"Mohammed I, Nauman A, Paul P, et al.. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum Vaccin Immunother. 2022, 18:2027160. 10.1080\/21645515.2022.2027160","journal-title":"Hum Vaccin Immunother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105729","article-title":"Efficacy of COVID-19 vaccines","volume":"171","author":"Saadh MJ","year":"2022","unstructured":"Saadh MJ, Jaber SA. Efficacy of COVID-19 vaccines. Microb Pathog. 2022, 171:105729. 10.1016\/j.micpath.2022.105729","journal-title":"Microb Pathog"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe0948","article-title":"Prospects for a safe COVID-19 vaccine","volume":"12","author":"Haynes BF","year":"2020","unstructured":"Haynes BF, Corey L, Fernandes P, et al.. Prospects for a safe COVID-19 vaccine. Sci Transl Med. 2020, 12:eabe0948. 10.1126\/scitranslmed.abe0948","journal-title":"Sci Transl Med"},{"key":"ref8","unstructured":"Advice for the public. coronavirus disease (COVID-19). (2023). Accessed: October 1, 2024: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/advice-for-public."},{"key":"ref9","unstructured":"Coronavirus (COVID-19) vaccinations. (2024). Accessed. October 1, 2024:  https:\/\/ourworldindata.org\/covidvaccinations."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S347669","article-title":"A global map of COVID-19 vaccine acceptance rates per country: an updated concise narrative review","volume":"15","author":"Sallam M","year":"2022","unstructured":"Sallam M, Al-Sanafi M, Sallam M. A global map of COVID-19 vaccine acceptance rates per country: an updated concise narrative review. J Multidiscip Healthc. 2022, 15:21-45. 10.2147\/JMDH.S347669","journal-title":"J Multidiscip Healthc"},{"key":"ref11","article-title":"Introduction to multivariate regression analysis","volume":"14","author":"Alexopoulos EC","year":"2010","unstructured":"Alexopoulos EC. Introduction to multivariate regression analysis. Hippokratia. 2010, 14:23-8.","journal-title":"Hippokratia"},{"key":"ref12","unstructured":"Seoul Metropolitan city_covid-19 vaccination status. (2024). Accessed. October 1, 2024: https:\/\/www.data.go.kr\/data\/15078073\/fileData.do."},{"key":"ref13","unstructured":"COVID-19 vaccination in South Korea. (2023). Accessed. October 1, 2024: https:\/\/en.wikipedia.org\/wiki\/COVID-19_vaccination_in_South_Korea."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61457","article-title":"Statistical assessment of the effectiveness of multiple COVID-19 vaccinations on daily confirmed cases in Seoul City","volume":"16","author":"Kim J","year":"2024","unstructured":"Kim J, Jung H. Statistical assessment of the effectiveness of multiple COVID-19 vaccinations on daily confirmed cases in Seoul City. Cureus. 2024, 16:e61457. 10.7759\/cureus.61457","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01699-1","article-title":"Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England","volume":"28","author":"Andrews N","year":"2022","unstructured":"Andrews N, Stowe J, Kirsebom F, et al.. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England. Nat Med. 2022, 28:831-7. 10.1038\/s41591-022-01699-1","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01832-0","article-title":"Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60\u2009years","volume":"28","author":"Arbel R","year":"2022","unstructured":"Arbel R, Sergienko R, Friger M, et al.. Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60\u2009years. Nat Med. 2022, 28:1486-90. 10.1038\/s41591-022-01832-0","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27697","article-title":"Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review","volume":"94","author":"Chenchula S","year":"2022","unstructured":"Chenchula S, Karunakaran P, Sharma S, Chavan M. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review. J Med Virol. 2022, 94:2969-76. 10.1002\/jmv.27697","journal-title":"J Med Virol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201688","article-title":"Fourth dose of BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"386","author":"Magen O","year":"2022","unstructured":"Magen O, Waxman JG, Makov-Assif M, et al.. Fourth dose of BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2022, 386:1603-14. 10.1056\/NEJMoa2201688","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.07.001","article-title":"Immune response in COVID-19: a review","volume":"13","author":"Chowdhury MA","year":"2020","unstructured":"Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID-19: a review. J Infect Public Health. 2020, 13:1619-29. 10.1016\/j.jiph.2020.07.001","journal-title":"J Infect Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v93i1.12210","article-title":"Delta variant: the new challenge of COVID-19 pandemic, an overview of epidemiological, clinical, and immune characteristics","volume":"93","author":"Samieefar N","year":"2022","unstructured":"Samieefar N, Rashedi R, Akhlaghdoust M, Mashhadi M, Darzi P, Rezaei N. Delta variant: the new challenge of COVID-19 pandemic, an overview of epidemiological, clinical, and immune characteristics. Acta Biomed. 2022, 93:e2022179. 10.23750\/abm.v93i1.12210","journal-title":"Acta Biomed"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Lopez Bernal J","year":"2021","unstructured":"Lopez Bernal J, Andrews N, Gower C, et al.. Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021, 385:585-94. 10.1056\/NEJMoa2108891","journal-title":"N Engl J Med"},{"key":"ref22","unstructured":"Update on Omicron. (2021). Accessed. October 1, 2024: https:\/\/www.who.int\/news\/item\/28-11-2021-update-on-omicron."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201570","article-title":"Protection by a fourth dose of BNT162b2 against Omicron in Israel","volume":"386","author":"Bar-On YM","year":"2022","unstructured":"Bar-On YM, Goldberg Y, Mandel M, et al.. Protection by a fourth dose of BNT162b2 against Omicron in Israel. N Engl J Med. 2022, 386:1712-20. 10.1056\/NEJMoa2201570","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/330571-statistical-analysis-of-multiple-vaccine-effectiveness-against-covid-19-variants-integrating-immune-response-dynamics","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T06:42:25Z","timestamp":1735713745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/330571-statistical-analysis-of-multiple-vaccine-effectiveness-against-covid-19-variants-integrating-immune-response-dynamics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.76705","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}